Meta-analysis of two-arm studies: Modeling the intervention effect from survival probabilities

Statistical Methods in Medical Research

Volumn 25, Issue 2, 2016, Pages 857-871

  Combescure, C ^a   Courvoisier, D S ^a   Haller, G ^a   Perneger, T V ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Meta analysis; multiple time points; survival data

Indexed keywords

HUMAN; META ANALYSIS; MODEL; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; ACUTE MYELOID LEUKEMIA; BREAST TUMOR; DISEASE FREE SURVIVAL; EARLY CANCER DIAGNOSIS; FEMALE; MORTALITY; TIME FACTOR; TUMOR RECURRENCE;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 84964294713     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280212469716     Document Type: Article

References (35)

1. Whitehead A, Meta-analysis of controlled clinical trials, Chichester: John Wiley & Sons, 2002
2. Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, et al. Survival end point reporting in randomized cancer clinical trials: a review of major journals. J Clin Oncol 2008; 26 (22): 3721-3726.
3. Moodie PF, Nelson NA, Koch GG,. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data. Stat Med 2004; 23 (7): 1075-1093.
4. Perneger TV,. Estimating the relative hazard by the ratio of logarithms of event-free proportions. Contemp Clin Trial 2008; 29 (5): 762-766.
5. Combescure C, Courvoisier D, Haller G, et al. Meta-analysis of binary outcomes from two-by-two tables when the length of follow-up varies and hazards are proportional. Stat Meth Med Res 2011; 20 (5): 10-10.
6. Dear KB,. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 1994; 50 (4): 989-1002.
7. Arends LR, Hunink MG, Stijnen T,. Meta-analysis of summary survival curve data. Stat Med 2008; 27 (22): 4381-4396.
8. Ouwens MJ, Philips Z, Jansen JP,. Network meta-analysis of parametric survival curves. Res Syn Meth 2010; 1 (3-4): 24-24.
9. Bennett S,. Analysis of survival data by the proportional odds model. Stat Med 1983; 2 (2): 273-277.
10. Royston P, Parmar MK,. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002; 21 (15): 2175-2197.
11. O'Quigley J, Stare J,. Proportional hazards models with frailties and random effects. Stat Med 2002; 21 (21): 3219-3233.
12. Yang S, Prentice RL,. Estimation of the 2-sample hazard ratio function using a semiparametric model. Biostatistics 2011; 12 (2): 354-368.
13. Sundaram R,. Semiparametric inference of proportional odds model based on randomly truncated data. J Stat Plan Infer 2009; 139 (4): 1381-1393.
14. Bennett S,. Log-logistic regression models for survival data. Appl Stat 1983; 32 (2): 165-171.
15. Berkey CS, Anderson JJ, Hoaglin DC,. Multiple-outcome meta-analysis of clinical trials. Stat Med 1996; 15 (5): 537-557.
16. Berrington A, Cox DR,. Generalized least squares for the synthesis of correlated information. Biostatistics 2003; 4 (3): 423-431.
17. Trikalinos TA, Olkin I,. A method for the meta-analysis of mutually exclusive binary outcomes. Stat Med 2008; 27 (21): 4279-4300.
18. Berkey CS, Hoaglin DC, Antczak-Bouckoms A, et al. Meta-analysis of multiple outcomes by regression with random effects. Stat Med 1998; 17 (22): 2537-2550.
19. Jackson D, White IR, Thompson SG,. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 29 (12): 1282-1297.
20. Begg CB, Pilote L, McGlave PB,. Bone marrow transplantation versus chemotherapy in acute non-lymphocytic leukemia: a meta-analytic review. Eur J Cancer Clin Oncol 1989; 25 (11): 1519-1523.
21. Lu WL, Jansen L, Post WJ, et al. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009; 114 (3): 403-412.
22. Fiocco M, Putter H, van Houwelingen JC,. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach. Stat Med 2009; 28 (30): 3782-3797.
23. Williamson PR, Smith CT, Hutton JL, et al. Aggregate data meta-analysis with time-to-event outcomes. Stat Med 2002; 21 (22): 3337-3351.
24. Conde E, Iriondo A, Rayon C, et al. Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: a prospective controlled trial. Br J Haematol 1988; 68 (2): 219-226.
25. Altman DG, De Stavola BL, Love SB, et al. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72 (2): 511-518.
26. Bellera CA, MacGrogan G, Debled M, et al. Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol 2010; 10: 20-20.
27. Siannis F, Barrett JK, Farewell VT, et al. One-stage parametric meta-analysis of time-to-event outcomes. Stat Med 2010; 29 (29): 3030-3045.
28. Cutler SJ, Ederer F,. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8 (6): 699-712.
29. Dorey FJ, Korn EL,. Effective sample sizes for confidence intervals for survival probabilities. Stat Med 1987; 6 (6): 679-687.
30. Parmar MK, Torri V, Stewart L,. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17 (24): 2815-2834.
31. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16-16.
32. Guyot P, Ades A, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012; 12 (1): 9-9.
33. Smith CT, Williamson PR, Marson AG,. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. J Eval Clin Pract 2005; 11 (5): 468-478.
34. Smith CT, Williamson PR, Marson AG,. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med 2005; 24 (9): 1307-1319.
35. Katsahian S, Latouche A, Mary JY, et al. Practical methodology of meta-analysis of individual patient data using a survival outcome. Contemp Clin Trial 2008; 29 (2): 220-230.